Link Reservations Inc. (Stock Symbol: LRSV) is an International Provider of Wellness Products For Animals & Humans. New Functional Mushroom Immunity Booster
Link Reservations Inc (OTCMKTS: LRSV)
KINGTON, HEREFORDSHIRE, UNITED KINGDOM, March 26, 2021 /EINPresswire.com/ — Link Reservations Inc. (Stock Symbol: LRSV) is an International Provider of Wellness Products For Animals and Humans
LRSV has a New Functional Mushroom Immunity Booster
Developer and Marketer of Wellness Products for People and Pets.
Wholly Owned Subsidiary Operates Commercially in Europe and the US.
Upcoming Launch of Immunity Boosting Functional Mushroom Product.
New DailyLife Immune Product Includes an Organic Blend of 13 Different Medicinal Mushrooms Plus CBD Extract and Vitamin C.
Link Reservations Inc., (LRSV) is a wellness product provider dedicated to improving the health and life conditions of both people and pets worldwide. LRSV trades through its two brands; LinkResPet and DailyLifeCBD. LinkResPet develops and markets hemp-based CBD products for cats, dogs and horses. DailyLifeCBD provides everyday hemp-based CBD wellness products for people. LSRV currently operations in both the US and Europe.
The American Veterinarian Association reports that there is an emerging trend of pet owners using CBD and CBD products to treat the symptoms of their pets, such as nausea, seizures, anxiety, arthritis and even cancer. LRSV products aid animals in the same ways that CBD has been shown to aid humans as well: easing the pain of arthritis, strengthening their immune systems, lessening anxiety.
A lot has been said about the usefulness of CBD products to the human body, an intensive level of research has been conducted to show how CBD can interact with the CB1 and CB2 endocannabinoid receptors to elicit their medical properties.
CBD (cannabidiol) is one of the numerous plant chemicals (cannabinoids) which have been known to elicit a wide range of medical properties such as anticancer, antidepressant, antioxidant, anti-inflammatory and antimicrobial activities. It is the second most abundant cannabinoid after tetrahydrocannabinol (THC). Not just in humans, the use of CBD oil for dogs, cats, and horses has been widely documented by several researchers.
Launch of Immunity Boosting Functional Mushroom Product for People
On March 24th LRSV announced the company is preparing to launch its first functional mushroom product, DailyLife CBD Immune. The new tincture product, tailored for people, will feature both CBD and a wide spectrum of functional mushrooms (including Lion’s Mane) which help boost the immune system.
LRSV has always been dedicated to providing high quality products to deliver the power of natural ingredients. With the pressure of the Coronavirus pandemic, understandably, people are focusing on their health now more than ever and looking for ways in which they can boost their immunity,
particularly in a natural way. The LRSV goal is to fully satisfy their need with this new product. LRSV has been researching the benefits of functional mushrooms for the past few months and has now developed a product that will harness their power. According to Rick Miller, Associate Director of Food & Drink Specialised Nutrition at Mintel, the majority of consumers in Europe purchase vitamins, minerals and supplements that strengthen the immune system, while in the US, 35% of consumers think products that support the immune health would motivate them when making a purchase.
LRSV notes that the benefits of the different mushroom varieties are wide-ranging. For example, some specific types of mushrooms have been shown to help increase mental clarity and assist with immune support. According to Mordor Intelligence, “A number of scientific studies have confirmed the ability of functional mushrooms and mushroom-derived supplements to increase the effectiveness of both innate and adaptive immune systems. The market is expected to experience huge demand for Reishi and Cordyceps, followed by the other types of medicinal mushrooms.”
Another example is the Lion’s Mane variety, which has shown to be “good for the brain”, as reported by The New York Times, as “a study published in 2011 showed the mushroom reduced memory loss symptoms in mice,” adding that in one study in older people “found that daily lion’s mane supplements improved their mental functioning”. Mushrooms in general have proved to have benefits for our immune system, according to dietitian Ryanne Lachman, as quoted by the Cleveland Clinic. “A big one tends to be with reducing inflammation. Mushrooms also contain antioxidants, which can help support the immune system.”
The LRSV DailyLife CBD Immune product will feature an organic blend of 13 different medicinal mushrooms, including Lion’s Mane, Turkey Tail, Chaga, Red Reishi and Cordyceps, amongst others. By focusing on a variety of mushrooms the product is able to encompass multiple immune boosting traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of hemp oil CBD extract and 100mg of vitamin C, which will add to the immune boosting benefits.
For more information about DailyLifeCBD visit: https://dailylifecbd.com/
LRSV Holds OTC Markets Current Information Reporting Standard
On December 9th LRSV announced that the company was up to date with all of its OTC Market filings and has achieved “Current Information” status, with no risk or yields signs associated with the stock on OTCMarkets.com. LRSV management has updated all financial reports and disclosure statements and remains in current status to date in order to provide full transparency to all of its shareholders and the investment community.
For more information on Link Reservations, Inc (LRSV) visit: https://www.linkreservationsinc.com
DISCLAIMER: FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. FPS/CA is NOT affiliated in any manner with any company mentioned herein. FPS/CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FPS/CA has been compensated $500 by the company for dissemination of this Article.
These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.